Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease

Diabetic kidney disease (DKD) is one of the most common microvascular complications of diabetes mellitus. However, the pathological mechanisms contributing to DKD are multifactorial and poorly understood. Diabetes is characterized by metabolic disorders that can bring about a series of changes in en...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengdi, Pang, Yanyu, Guo, Yifan, Tian, Lei, Liu, Yufei, Shen, Cun, Liu, Mengchao, Meng, Yuan, Cai, Zhen, Wang, Yuefen, Zhao, Wenjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479190/
https://www.ncbi.nlm.nih.gov/pubmed/36120335
http://dx.doi.org/10.3389/fphar.2022.970601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479190/
https://www.ncbi.nlm.nih.gov/pubmed/36120335
http://dx.doi.org/10.3389/fphar.2022.970601

Ejemplares similares